Positive Sentiment Still Eludes ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Following 30% Share Price Slump

Simply Wall StNov 23 07:43 ET

ImmunoPrecise Antibodies Advances in Cancer Therapy Development

TipRanksNov 13 09:48 ET

$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies

Business WireNov 13 09:00 ET

ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation

BusinesswireNov 4 08:01 ET

Express News | ImmunoPrecise Highlights Publication Of Mayo Clinic Scientist-Led Research In BioRxiv And Autophagy Titled 'Development and Characterization of Phospho-Ubiquitin Antibodies to Monitor PINK1-PRKN Signaling in Cells and Tissue'

BenzingaOct 28 07:32 ET

ImmunoPrecise Advances Anti-Aging Research With Mayo Clinic Study, Poised to Tap Into $81 Billion Market With AI Technology

BusinesswireOct 28 07:30 ET